AUM $15.1MER 0.95%NAV $17.77Holdings 1Inception Jun 2015
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
—Dividend Yield
—Expense Ratio
0.95%AUM
$15.1MShares Outstanding
849.3KETF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Cash & Others | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| Other | 100.00% |
Fund Information
- Issuer
- ProShares
- Category
- Cash & Others
- Inception Date
- Jun 22, 2015
- Description
- The investment seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the NASDAQ Biotechnology Index (the index). The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Similar ETFs
The ProShares UltraPro Nasdaq Biotechnology (UBIO) is an exchange-traded fund issued by ProShares that launched on Jun 22, 2015. It currently manages $15.1M in assets under management. The fund charges an expense ratio of 0.95%. The fund holds 1 securities in its portfolio. It falls under the Cash & Others category.
Top 10 holdings represent 100.0% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | — | Net Other Assets (Liabilities) | 100.00% | 15,100,402 | $15.1M |
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
—
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | UBIO | Cash & Others(1140 ETFs) | Biotech(41 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.95% | 0.67% | 0.86% |
| AUM | $15.1M | $1.85B | $1.84B |
| Dividend Yield | — | 9.56% | 1.97% |
| Avg Volume | — | 759.2K | 1.4M |
| Holdings | 1 | 251 | 63 |
| Performance | |||
| 1-Month Return | — | -1.95% | -1.63% |
| 6-Month Return | — | +6.46% | +21.82% |
| YTD Return | — | +1.62% | +20.41% |
| 1-Year Return | — | +1.09% | +16.65% |
Compare with Another ETF
Search for an ETF to compare with UBIO:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.